Medical Capital Advisors, Serving as Exclusive Investment Banking Advisor to CeraPedics, Announces $14.45 Million Private Equity Financing

WALTHAM, Mass.--(BUSINESS WIRE)--Medical Capital Advisors (www.medcapadvisors.com) announced today that its client, CeraPedics, Inc., has closed on a $14.45 million private equity financing from OrbiMed Advisors, LLC (www.orbimed.com). Medical Capital Advisors served as investment banking advisor for CeraPedics.

Privately held CeraPedics (Lakewood, Colo.) is a medical device company working toward commercializing products for the orthopedic bone graft substitutes market based on its proprietary small peptide technology.

About Medical Capital Advisors, LLC

Medical Capital Advisors, LLC (www.medcapadvisors.com) is among Wall Street’s leading, specialized investment banking advisors to the Medical Technology industry. The firm has successfully represented the financial interests of sophisticated institutional investors and Fortune 500 companies. Medical Capital Advisors’ current client base includes leading medical technology firms in the largest sectors of medicine, including: orthopedic, cardiovascular, and biologic sciences. Medical Capital Advisors provides strategic advice concerning mergers and acquisitions, strategic partnerships, and capital investments to its clients.